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The eye generally is considered to be an immune-privileged organ, but this
notion is being increasingly challenged as ocular antigens can be expressed in the
generative lymphoid organs, resulting in attainment of self-tolerance. What
triggers a break in this tolerant state is a fundamental question in autoimmunity
research. The general belief is that exposure to environmental microbes can break
self-tolerance in genetically susceptible individuals, leading to the induction of
autoimmune responses. The molecular mimicry hypothesis has been proposed as
one major mechanistic, pathway through which microbes, by generating cross-
reactive immune responses, can induce ocular damage of the kind that might
occur in uveitis. However, our recent data suggest that exposure to microbial
products containing mimicry epitopes for retinal antigens can potentially be
beneficial to the host. In this review, we discuss the immune mechanisms with
particular reference to the molecular mimicry hypothesis as it relates to immune-
mediated uveitis.
Introduction
Uveitis is inflammation of the uvea, an area of the eye
consisting of the iris, ciliary body and choroid layer, but
when the retina is involved, the disease process is described
as uveoretinitis [1]. However, based on the anatomic
location of lesions, uveitis has also been categorized as
anterior uveitis (cornea, anterior chamber, iris, ciliary body
and lens), intermediate uveitis (vitreous humour, pars plana
of the ciliary body and peripheral retina) and posterior
uveitis (vitreous gel, retina, retinal vessels, choroid and
optic nerve) [2]. For diagnostic purposes, identification of
lesions in specific regions becomes a critical necessity, but
in this review, to simplify understanding, we use the
broader term uveitis to describe the disease process,
regardless of the region of inflammation involved.
Uveitis is the fourth leading cause of blindness in the
Western world, affecting approximately 300,000 individ-
uals in the United States alone [3]. The disease incidence is
high in individuals aged 25–44 years [4]. The clinical
course of uveitis is characterized by sudden or insidious
onset, lasting up to 3 months or even longer [5]. Uveitic
conditions can be of infectious or non-infectious origin. In
various eye diseases or systemic diseases affecting the eye,
such as Behcet’s disease, Vogt–Koyanagi–Harada (VKH)
syndrome, birdshot chorioretinopathy, systemic sarcoidosis
and sympathetic ophthalmia, autoimmune responses
arising from recognition of eye antigens as foreign have
been suspected. Generally, it is held that exposure to
microbes can trigger autoimmune responses in genetically
susceptible individuals and may involve a combination of
various mechanisms, such as molecular mimicry, epitope
spreading, bystander activation and release of cryptic
antigens [6–8]. In this review, we discuss the mechanisms
of immune-mediated ocular damagewith an emphasis on the
molecularmimicry hypothesis as it relates to the induction of
cross-reactive T cells in the mediation of uveitis.
The eye as an immune-privileged organ
Traditionally, the eye is considered an immunologically
privileged organ, and several mechanisms have been
postulated to explain this phenomenon. (1) The two
components of the blood–ocular barrier (BOB), which is
comprised of the blood aqueous barrier (non-pigmented
epithelium of the ciliary body and the vascular endothe-
lium of the iris) and the blood retinal barrier (vascular
endothelium of the retinal blood vessels and the retinal
pigment epithelium [RPE]), protect the intraocular com-
ponents from access to lymph or blood and control
trafficking of immune cells, including na€ıve T cells, into
the eye [9]. (2) The phenomenon of anterior chamber-
associated immune deviation (ACAID) causes induction of
peripheral T regulatory (Treg) cells. In this process, after
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the initial encounter with an antigen, the antigen-
presenting cells (APCs) escape from the eyes and traffic
selectively to the marginal zone of the spleen, promoting
distinct populations of CD4 and CD8 Tregs [10]. (3)
Specialized APCs cannot efficiently stimulate na€ıve T cells,
as suggested by the finding that dendritic cells (DCs) in the
eye respond poorly to conventional APC assays [11]. (4)
Immunomodulatory factors in the aqueous humour, such as
transforming growth factor (TGF)-b, interleukin (IL)-1
receptor antagonist, vasoactive intestinal peptide (VIP),
inhibitors of C1q and C3 convertase, and macrophage
migration inhibitory factor (MIF), can suppress activation
of macrophages, neutrophils, T cells and the complement
cascade. In these factors, TGF-b2 and a-melanocyte-
stimulating hormone favour the induction of peripheral
Treg cells from the eye [12, 13]. (5) In the immune
regulatory environment, resident macrophages can mimic
the Treg properties of TGF-b-primed macrophages [14].
Iris, ciliary body and RPE structures also can promote
Tregs [15]. It recently has been shown that RPE can express
ligands for programmed death-1 receptor, cytotoxic T cell-
associated antigen-2a, and cathepsin L inhibitor that may
involve induction of Tregs and suppression of the differ-
entiation of T-helper (Th) cells [16, 17].
In spite of these immune barriers, the eye still can
become vulnerable to infectious and non-infectious
assaults, leading to the development of chronic uveitic
conditions in which autoimmune responses are suspected.
As exemplified in Fig. 1, the potential role of autoreactive
T cells in the causation of ocular damage can be best
illustrated in sympathetic ophthalmia, a bilateral granu-
lomatous uveitic condition that can be seen after surgical
procedures or traumatic injuries to the eyes [18, 19]. In this
disease process, T cells that might be generated in response
to ocular antigens such as uveal melanin, retinal S-antigen
(S-Ag; also called as retinal arrestin), rhodopsin, interpho-
toreceptor retinoid-binding protein (IRBP) and recoverin
released from one damaged eye can induce inflammatory
response in the unaffected eye. Essentially, the naive T cells
responding to the ocular antigens draining into the
regional lymph nodes become activated, and the effector
T cells then infiltrate the healthy eye and recruit
neutrophils and macrophages, leading to damage to the
previously unaffected eye [20].
Factors that predispose to uveitis
The peripheral repertoires of healthy individuals may
contain self-reactive T cells and B cells; before they are
exported to the periphery, both cell types have to interact
with self-antigens during their selection processes in the
thymus and bone marrow, respectively [21]. Therefore,
hypothetically, healthy humans can have a propensity to
develop autoimmune diseases, but the clinical symptoms
are manifested in very few of them. How such tolerance is
maintained is fundamental to the understanding of
autoimmune diseases. Two major factors have been impli-
cated in the predisposition to autoimmune diseases: genetic
susceptibility and exposure to environmental microbes.
Genetic susceptibility
Major histocompatibility complex (MHC) genes play a role
in disease susceptibility, and strong associations have been
found between acute anterior uveitis and human leucocyte
antigen (HLA)-B27 [22], between Behcet’s disease and
HLA-B51, and between VKH disease and HLA-DR4 and
HLA-DQ4 haplotypes, whereas birdshot retinochoroidopa-
thy and sympathetic ophthalmia are linked with HLA-A29
and HLA-DR4 haplotypes, respectively [23–25]. MHC locus
is an important determinant of T cell responses because T
cells can recognize peptide antigens presented by APCs only
in the context of MHC molecules. During the maturation
process within the thymus, T cells have to recognize both
MHC molecules and self-antigens; high-affinity interactions
lead to negative selection, as opposed to weak interactions
that favour positive selection of T cells [21].
However, it is possible for T cells to escape negative
selection if the antigen presentation pathways are defective
[21], or if the thymus fails to express self-antigens. The
latter is controlled by autoimmune regulatory element
(AIRE), both a transcriptional factor and a non-MHC gene
that influences central tolerance and controls the thymic
expression of self-proteins [21]. Two lines of evidence
support the notion that AIRE plays a critical role in central
tolerance: (1) humans possessing point mutations in AIRE
exhibit a wide array of autoimmune diseases [26] and (2)
AIRE-deficient mice develop multi-organ autoimmunity,
including uveitis, in which autoantibodies for a wide range
of antigens have been demonstrated in heart, liver, testes,
pancreas, adrenal glands and eyes [27]. Further, failure to
express a self-antigen in the AIRE-sufficient mice can lead
to organ-specific autoimmunity [28]. However, the long-
standing notion that ocular antigens are sequestered and not
expected to be recognized by the developing thymocytes is
increasingly being challenged, as demonstrated by expres-
sion of various retinal antigens within the thymus, such as
IRBP, S-Ag, recoverin, opsin, RPE-65 and melanocyte-
specific antigens [29, 30]. Nonetheless, alterations, if any, in
the amounts of protein expression can still affect thymic
education of T cells, leading to their safe exit into the
periphery [31, 32]. In genetically susceptible individuals,
self-reactive T cells in such a pre-existing repertoire can be
activated to become pathogenic cells that might occur in
response to exposure to environmental microbes.
Environmental microbes
Generally, it is believed that microbial infections can
trigger autoimmune responses in susceptible individuals. A
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variety of pathogens such as viruses, bacteria, protozoa and
fungi have been implicated in the causation of uveitic
conditions (Table S1). But, the challenge is to delineate the
underlying mechanisms for the persistence of chronic
inflammation in the absence of detectable infectious
particles. Under these circumstances, autoimmune
responses are suspected, and molecular mimicry is one
major mechanism implicated in the mediation of autoim-
mune diseases of microbial origin [33].
Molecular mimicry is a phenomenon in which the
structural similarities between self- and non-self (foreign)-
antigens facilitate recognition of self-antigens by cross-
reactivity, which can occur at the level of T cells or
antibodies [33, 34]. Antibodies can recognize linear
microbial sequences, as well as homologous non-identical
sequences, and they can trigger inflammatory reactions
through the activation of complement cascade [35]. For T
cells, cross-reactivity occurs as a result of degeneracy in the
recognition of peptides presented by MHC molecules
(Fig. 2a). T cell degeneracy has been noted in microbial
products showing stretches of sequences identical to the
self-proteins [36]. Importantly, peptide fragments bearing
even minimal sequence identities can still be recognized by
T cells, if the critical MHC- and T cell receptor (TCR)-
contact residues are preserved in the mimicry epitopes [37,
38]. Thus, potential exists for microbes to trigger autoim-
mune diseases such as uveitis via molecular mimicry.
To determine the pathogenic potential of uveitis-
inducing mimicry epitopes, experimental autoimmune
uveoretinitis (EAU) models are commonly employed
[39]. EAU can be induced in susceptible rodent species
by immunizing them with proteins or their peptides
extracted primarily not only from the retina but also from
iris and ciliary body, in complete Freund’s adjuvant. The
uveitogenic proteins include S-Ag, IRBP, rhodopsin,
recoverin, phosducin, RPE-65 and type I collagen [40–
42]. Although the CAR and PVG strains of rats are
susceptible to S-Ag-mediated EAU, the disease can be
induced in Lewis rats with both S-Ag and IRBP [7, 41]. In
contrast, EAU can be induced in mice only with IRBP; its
Figure 1 Proposed immune mechanisms of uveitis. The eye is generally considered to be an immune-privileged organ, and several factors contribute to
the immunosuppressive environment within the eye: blood–ocular barrier; specialized antigen-presenting cells (APCs); immunomodulatory factors such
as TGF-b, VIP and macrophage migration inhibitory factor (MIF); and Tregs (i). Nonetheless, exposure to pathogens that have a tropism for the eye can
lead to ocular damage by direct injury (ii). Alternatively, microbes bearing the mimicry sequences of ocular antigens can induce the generation of cross-
reactive T cells in the periphery, which then enter the eyes and induce ocular inflammation through molecular mimicry (iii). Consequently, new ocular
antigens can be released and drained into the local lymph nodes, leading to the generation of self-reactive T cells that are capable of producing
proinflammatory Th1 and Th17 cytokines, which can then migrate back into both the affected and the healthy eye (iv). As this vicious cycle continues,
chronic inflammation sets in (v).
 2015 John Wiley & Sons Ltd
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uveitogenic epitopes include IRBP 161-180, IRBP 171-
190 and IRBP 541-560 in B10.RIII mice; IRBP 201-216
in B10.A, B10.BR and A/J mice; and IRBP 1-20, IRBP
461-480 and IRBP 651-670 in C57BL/6 mice. In all these
models, autoreactive T cells are implicated in the disease
pathogenesis [7, 43–45]. As in other autoimmune diseases,
the skewed T-helper cytokines (most importantly, Th17
cytokines) are considered to be proinflammatory in EAU
pathogenesis, whereas Th2 cytokines mediate a disease-
suppressive role, suggesting that the pathogenic mimicry
epitopes induce Th17 cytokine-producing cross-reactive T
cells [46, 47].
Mimicry epitopes capable of inducing uveitis have been
reported from various sources including self-protein, milk
protein and microbes. Peptides from the HLA-B (HLA-
B27PD 125-138), bovine a2-casein (Cas 73-84) and the
viral outer capsid protein (VP) 4 of rotavirus (VP4 591-
601) that mimic the cognate epitope, S-Ag 341-355, have
been shown to induce uveitis in Lewis rats through the
induction of cross-reactive T cells (Table S2) [48, 49].
Similarly, a panel of disease-inducing mimicry epitopes for
another epitope of the S-Ag (S-Ag 303-320) also has been
identified from a number of sources. These include two
peptides from the hypothetical protein of Escherichia coli
(ECHP 9 and ECHP 11); three viral peptides, one each
from hepatitis B virus DNA polymerase (HBVDP 404-
415), gag-pol polyprotein of AKV murine leukaemia virus
(AKVMLVGP 347-358) and gag-pol polyprotein of
baboon endogenous virus (BEVGP 354-365); and a peptide
from the potato proteinase IIa (Table S2) [50–52].
It is a common belief that exposure to microbes
containing mimicry epitopes for self-antigens leads to the
induction of pathogenic cross-reactive T cells or autoan-
tibodies [33, 53, 54]. However, recently, using IRBP 201-
216 as a target antigen, we identified a total of 48 novel
mimicry sequences from various microbial sources, and one
of these, Ehrlichia canis (EHC) 44-59, induced cross-
reactive T cells for IRBP 201-216 (Fig. 2b) [55]. Of note,
EHC is a species-specific rickettsial pathogen that can
induce uveitis and optic neuritis in dogs, but autoimmune
responses have not been investigated in the affected
animals [56, 57]. In our hands, in spite of its ability to
produce uveitogenic Th1 and Th17 cytokines, EHC 44-59
failed to induce EAU. Rather, the mimicry epitope
suppressed EAU induced with IRBP 201-216, an effect
attributable to its ability to act as a naturally occurring
altered peptide ligand (APL). Such a phenomenon also has
been previously reported for one other self-antigen, myelin
basic protein 87-99, in the context of experimental
autoimmune encephalomyelitis [58], raising the question
as to the relevance of molecular mimicry in the mediation
of autoimmune diseases, ocular diseases in particular.
Furthermore, similar to T cells, cross-reactive autoanti-
bodies can also be generated in response to exposure to
environmental microbes carrying the mimicry epitopes,
such as streptococcal M protein for S-Ag; leptospiral
recurrent uveitis (lru) A-associated proteins for alpha-
crystallin B and lru B for vimentin and beta-crystallin B2
[59]; and Klebsiella components for vitreous humour
antigens [60, 61]. Likewise, reports indicate that
A B
Figure 2 T cell degeneracy in the recognition of major histocompatibility complex (MHC)-bound peptides. (a) T cell degeneracy. T cells recognize
peptides in the context of MHC molecules through their receptors. The peptides are comprised of critical residues with extended side chains that anchor
the peptide to the MHC molecule, whereas the side chains from the solvent-exposed residues interact with the T cell receptors (TCRs). The major and
minor contact residues at indicated positions (P) corresponding to MHC and TCR contacts are shown. In some instances, a single residue as shown at P7
can interact with both MHC and TCR. T cell recognition of peptides is degenerate, which can be explained by the fact that peptide recognition can occur
even if the major MHC or TCR contacts alone are conserved in the peptide. This forms the basis for the phenomenon of molecular mimicry in which
microbial epitopes that share partial sequence identity, but with conserved critical residues, can lead to the activation of cross-reactive immune responses.
(b) Comparison of sequences between cognate [interphotoreceptor retinoid-binding protein (IRBP)] and mimicry [Ehrlichia canis (EHC)] epitopes. The
amino acid sequences between IRBP 210-216 and EHC 44-59 showing an overall identity of 56% were compared to indicate the similar and dissimilar
residues between the two.
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autoantibodies can be present in microbial infections
independent to the generation of cross-reactive immune
responses. For example, rabbits infected with Toxoplasma
gondii show antibodies for S-Ag and retinal peptide-35
[62]. Similarly, autoantibodies to the human retinal extract
have been demonstrated in patients affected with chronic
toxoplasmosis showing no apparent symptoms [63]. Like-
wise, antibodies to retinal Gal-1 and S-Ag were found to
be elevated in patients with toxoplasmic retinochoroiditis
[64, 65]. Although, similar associations have been reported
for various other microbes, such as Yersinia spp [66, 67],
Mycobacterium spp [68], Bartonella spp [69], Helicobacter
pylori [70] and Leptospira interrogans [71], the pathological
significance of autoantibodies in all of these infections is
not known.
As illustrated in Fig. 3, microbes can cause ocular
damage regardless of their tropism for eyes, but their
disease-inducing mechanisms may vary. Oculotropic
pathogens can break the BOB, causing direct physical
injury to the tissues, resulting in acute uveitis. Tissue
destruction also can be mediated by toxins and proteases
secreted by microbes leading to the release of ocular
antigens, such as IRBP, recoverin, uveal melanin, retinal S-
Ag, phosducin, rhodopsin/opsin or tyrosinase-related pro-
teins 1 and 2, which may be then recognized by the
immune system as foreign [72–74]. As infections become
established, inflammatory cells are recruited to the local
milieu, further aggravating tissue damage. Ocular diseases
induced by microbes, however, can be spontaneously
resolved as the pathogens are cleared with or without
treatment. But if the pathogens continue to persist,
affected individuals can develop chronic disease. Alterna-
tively, exposure to environmental microbes carrying the
mimicry epitopes for retinal antigens, regardless of their
tropism for eyes, can have three consequences: (1) immune-
mediated damage can occur as a result of the induction of
pathogenic cross-reactive T cell responses, leading to the
induction of acute and chronic damage to the eyes. During
this process, new ocular antigens can be released, which
may become targets for immune recognition resulting in
the activation of a new repertoire of autoreactive T cells.
This phenomenon is termed ‘epitope spreading’, the outcome
of which is perpetuation of inflammation [75]. (2)
Induction of cross-reactive T cells with no pathologic
outcomes, or so-called sterile responses, can occur. (3)
Cross-reactive T cells that appear may prove to be beneficial
for the host, as we have shown with the mimicry epitope,
EHC 44-59, which has the ability to suppress the disease
induced with IRBP 201-216 by acting as APL [55].
Alternatively, given that Treg cells play a critical role in
suppressing the expansion of autoreactive effector T cell
responses, it may be possible that T cell recognition of
microbial antigens carrying the mimicry epitopes may lead
to the generation of Treg cells, thereby suppressing the
pathogenic cross-reactive immune responses as previously
proposed [76].
Figure 3 Hypothetical outcomes of ocular diseases of infectious origin. Oculotropic microbes can cause acute uveitis, and the inflammation is resolved as
the pathogen is cleared spontaneously or with treatment. But when pathogens persist, they can lead to chronic inflammation. Conversely, exposure to
microbes bearing mimicry epitopes, regardless of their specificity for eyes, can induce cross-reactive immune responses with varying outcomes, including
chronic disease, no disease or disease suppression via altered peptide ligand (APL) mechanism. Nevertheless, if chronic inflammation sets in as a result of
initial damage caused by the pathogen per se or through the induction of uveitogenic cross-reactive immune responses, then new ocular antigens can be
released as a result of epitope spreading and may become targets for immune attack. The outcome of these events is perpetuation of inflammation. This is a
likely reason for the persistence of chronic inflammation in the absence of detectable infectious particles, where autoimmune responses are suspected in
ocular infections.
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Conclusion
Previously, mimicry epitopes identified for various retinal
antigens have been shown to induce EAU in Lewis rats.
Based on our data in the mouse model of EAU [55], we
propose that exposure to microbes bearing the mimicry
epitopes for ocular antigens does not necessarily lead to
disease; rather, the mimics can suppress the disease.
Ironically, such a phenomenon has been documented for
one other immune-privileged organ – the central nervous
system [58]. We theorize that in typical host–parasite
relationships, microbes carrying mimicry epitopes can
induce pathogenic cross-reactive immune responses, and
such outcomes are not favourable for survival of parasites.
Alternatively, it may be possible that as parasites coexist
with hosts, they can acquire the host’s genetic material,
leading to their survival by promoting tolerance [77].
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Supplementary Table 1. Potential infectious and non-infectious triggers of uveitis 
Infectious triggers Reference Non-infectious triggers Reference 
Viruses  Physical/traumatic injuries [1] 
Varicella zoster virus  [2] Chemical injuries [3] 
Herpes simplex Virus  [4] Surgical maneuvers [5] 
Cytomegalovirus  [6] Radiation exposure [7] 
Epstein Barr virus  [8] Ocular tumors [9] 
West Nile virus  [10]   
Dengue virus  [11]   
Chikungunya virus  [12]   
Rift valley fever virus  [13]   
Influenza A (H1N1)  [14]   
Human T-lymphotropic virus  [15]   
Parvovirus B19  [16]   
Hepatitis C virus  [17]   
Human herpes virus 6  [18]   
Human parechovirus  [19]   
Human immunodeficiency virus  [20]   
Rubella virus  [21]   
Bacteria    
Treponema pallidum  [22]   
Mycobacterium tuberculosis  [23]   
Rickettsia spp  [24]   
Brucella abortus  [25]   
Staphylococcus aureus [26]   
Pseudomonas aeruginosa [27]   
Borreilia burgdorferi  [28]   
Leptospira spp  [29]   
Bacillus cereus  [30]   
Enterococcus faecalis [31]   
Protozoa    
Toxoplasma gondii  [32]   
Toxocara canis  [33]   
Onchocerca spp  [34]   
Cysticercus cellulosae  [35]   
Fungi    
Aspergillus spp  [36]   
Candida spp  [37]   
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Supplementary Table 2. Mimicry epitopes that can induce EAU in Lewis rats 
Retinal 
antigen 
Source of mimicry 
epitopes 
Peptide sequence‡ Reference 
S-Ag 341-354  FLGELTSSEVATEV  
 VP4 591-601    WTEVSEVATEV [1] 
 Cas 73-84    SEESAEVATEEV [1] 
 HLA B27PD 125-138  [1] 
    
S-Ag 303-320    DTNLASSTIIKEGIDKTV  
 HBVDP 404-415   LTNLLSSNLSWL [2] 
 BEVGP 354-365   PTNLAKVRTITQ [2] 
 AKVMLVGP 347-358   PTNLAKVKGITQ [2] 
 PPI IIa 25-36   DTNIASYKSVCE [2] 
 Histone H3 peptide 106-121   DTNLAAIHAKRVTIQK [3] 
 ECHP 9-22 DWLANLASSTQLCK [4] 
 ECHP 11-24   LANLASSTQLCKKN [4] 
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